25CN-NBOH

From WikiMD's WELLNESSPEDIA

25CN-NBOH

Chemical structure of 25CN-NBOH

25CN-NBOH is a chemical compound that belongs to the NBOH series of phenethylamines. It is a derivative of the 2C family of psychedelic compounds, specifically related to 2C-CN.

Chemical Structure[edit]

25CN-NBOH is characterized by the presence of a 2,5-dimethoxyphenethylamine core structure, with a cyano group at the 4-position of the phenyl ring. The NBOH series is distinguished by the presence of a 2-hydroxybenzyl group attached to the nitrogen atom of the phenethylamine backbone.

Pharmacology[edit]

25CN-NBOH acts as a potent agonist at the 5-HT2A receptor, which is a subtype of the serotonin receptor. This receptor is primarily responsible for the hallucinogenic effects of many psychedelic compounds. The binding affinity and efficacy of 25CN-NBOH at this receptor contribute to its psychoactive properties.

Effects[edit]

The effects of 25CN-NBOH are similar to those of other psychedelic phenethylamines, including altered perception, mood changes, and visual hallucinations. The intensity and duration of these effects can vary depending on the dose and individual sensitivity.

Legal Status[edit]

The legal status of 25CN-NBOH varies by country. In some jurisdictions, it may be classified as a controlled substance due to its structural similarity to other regulated psychedelics. Users should be aware of the legal implications of possessing or distributing this compound.

Safety and Toxicity[edit]

As with many research chemicals, the safety profile of 25CN-NBOH is not well-established. There is limited data on its toxicity, potential for abuse, and long-term health effects. Caution is advised when handling or experimenting with this compound.

Related Compounds[edit]

Related Pages[edit]

Gallery[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Retrieved from "https://wikimd.org/index.php?title=25CN-NBOH&oldid=6288293"